2025 Financial Calendar
28. February 2025
News Release:
The board has decided that Pharma Equity Group A/S will in future only submit half-yearly financial reports.
This means changes to the previously announced financial calendar for 2025. The current financial calendar for 2025 will look like this:
| Pharma Equity Group 2025 Financial Calendar | |
| March 4 | Deadline for shareholder proposals - Annual General meeting |
| March 20 | Annual Report 2024 |
| April 16 | Annual General Meeting |
| August 14 | Interim Report – for the six-month period ended June 30, 2025 |
Contact person – Investor Relations
On the Company’s website www.pharmaequitygroup.com further information and all published announcements can be found.
Inquiries regarding relations with investors and the stock market can be directed to: Thomas Kaas Selsø, CEO, Phone: +45 4022 2114 E-mail: investor@pharmaequitygroup.com.
About Pharma Equity Group A/S
Pharma Equity Group, a listed company on the Nasdaq Copenhagen stock exchange, is fully dedicated to advancing the medical projects of its subsidiary, Reponex Pharmaceuticals A/S. With an unwavering focus on healthcare, Pharma Equity Group 's primary objective is to bring significant value to Reponex Pharmaceuticals ' medical projects.
The company is committed to providing extensive support, resources, and expertise to drive the development and success of these projects. As a strategic partner, Pharma Equity Group works closely with Reponex Pharmaceuticals, prioritizing the advancement of innovative medical solutions and breakthrough therapies. This approach ensures a strong commitment to the current medical projects and their development, while – on the longer term – remaining open to new strategic investments for continuous growth.
Attachment
© 2025 GlobeNewswire, Inc. All Rights Reserved.
